0001209191-23-004872.txt : 20230125
0001209191-23-004872.hdr.sgml : 20230125
20230125175028
ACCESSION NUMBER: 0001209191-23-004872
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230123
FILED AS OF DATE: 20230125
DATE AS OF CHANGE: 20230125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jaen Juan C.
CENTRAL INDEX KEY: 0001422996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 23553384
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-23
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001422996
Jaen Juan C.
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
1
1
0
0
President
Common Stock
2023-01-23
4
A
0
45800
0.00
A
324682
D
Common Stock
1222240
I
By Trust
Stock Option (right to buy)
22.02
2023-01-23
4
A
0
185900
0.00
A
2033-01-22
Common Stock
185900
185900
D
Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company.
The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company.
/s/ Carolyn Tang, Attorney-in-Fact
2023-01-25